Prognosis of acute coronary syndrome complicated by stress hyperglycemia after percutaneous coronary intervention therapy

被引:1
|
作者
申健 [1 ]
李志明 [1 ]
何丽珍 [1 ]
刘锦光 [1 ]
申源生 [1 ]
罗晓丽 [1 ]
机构
[1] Department of Cardiology,Huizhou Municipal Central Hospital
关键词
stress hyperglycemia; acute coronary syndrome; prognosis;
D O I
暂无
中图分类号
R541.4 [冠状动脉(粥样)硬化性心脏病(冠心病)];
学科分类号
1002 ; 100201 ;
摘要
Background Several studies have reported an association of hyperglycemia with increased mortality and complications in hospital patients with acute coronary syndrome(ACS).However,the influence of stress hyperglycemia(SH)on the medium-and long-term prognoses in ACS patients has not yet been determined.Methods Random venous blood glucose levels were determined in 433 ACS patients and the patients were divided into two groups based on blood glucose results and disease histories.The 171 patients included in the experimental group had no history of diabetes,had no diabetes and/or glucose metabolism disorders during hospitalization and follow-up and had fasting blood glucose levels of≥7.0 mmol/L and random blood glucose levels≥11.1 mmol/L.The 262 patients included in the control group had no history of diabetes,had no diabetes and/or glucose metabolism disorders during hospitalization and follow-up,and had fasting blood glucose levels<6.1 mmol/L and random blood glucose levels<7.8 mmol/L.Basic clinical information,coronary angiographic lesion characteristics,PCI success rate,complication rate,incidence and morbidity rate of cardiovascular events during the hospitalization period and 6 years of follow-up were compared between the two groups.Results There was no significant difference in age,gender or disease history between the two groups.The triglyceride levels and the left ventricular ejection fractions were significantly higher(P=0.00)and significantly lower(P=0.03)in the experimental group than in the control group,respectively.Both groups were subjected to coronary angiography and PCI.The PCI success rates of the two groups did not differ significantly(P=0.63).The experimental group had more type B2 lesions,but fewer type A lesions compared with the control group.The experimental group had significantly more stents implanted compared with the control group(P<0.05).The cardiovascular events were significantly increased(P=0.01)in the experimental group compared with the control group 1 year after discharge.The incidence of cardiovascular events did not differ significantly between the two groups 1-2 years after discharge.The event incidences were significantly higher(P=0.05)in the experimental group than in the control group at the end of follow-up.The experimental group was more prone to myocardial infarction and ischemic target vessel revascularization than the control group,but the control group was more prone to unstable stenocardia and heart failure than the experimental group.The psychogenic mortality of the two groups were similar.The interval and the overall mortality rates(P=0.054)of the two groups were also similar.Conclusions Patients with ACS complicated by SH were more likely to have cardiovascular events 1 year after PCI,whereas SH did not affect the mid-or long-term prognoses of these patients.SH is an independent risk factor for cardiovascular events.
引用
收藏
页码:243 / 251 +256
页数:10
相关论文
共 50 条
  • [21] THE ROLE OF PULSE PRESSURE IN THE IMMEDIATE PROGNOSIS OF PATIENTS WITH ACUTE CORONARY SYNDROME UNDERGOING PERCUTANEOUS CORONARY INTERVENTION
    Li Mingyan
    Cui Yongsheng
    Zhao Leilei
    He Wenkai
    Cai Meifeng
    Wang Yuting
    Cui Yongsheng
    JOURNAL OF HYPERTENSION, 2018, 36 : E180 - E180
  • [22] ADVANCIS Score Predicts Acute Kidney Injury After Percutaneous Coronary Intervention for Acute Coronary Syndrome
    Fan, Pei-Chun
    Chen, Tien-Hsing
    Lee, Cheng-Chia
    Tsai, Tsung-Yu
    Chen, Yung-Chang
    Chang, Chih-Hsiang
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2018, 15 (05): : 528 - 535
  • [23] De-escalation of Antiplatelet Therapy After Percutaneous Coronary Intervention in East Asian Patients With Acute Coronary Syndrome
    Li, Wenhui
    Zhou, Shuang
    Zhang, Hanxu
    Wang, Zhe
    Mu, Guangyan
    Xie, Qiufen
    Liu, Zhiyan
    Hua, Manqi
    Cui, Yimin
    Xiang, Qian
    CLINICAL THERAPEUTICS, 2024, 46 (02) : 114 - 121
  • [24] Duration of Dual Antiplatelet Therapy in Patients with an Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
    Bavishi, Chirag
    Trivedi, Vrinda
    Singh, Mandeep
    Katz, Edward
    Messerli, Franz H.
    Bangalore, Sripal
    AMERICAN JOURNAL OF MEDICINE, 2017, 130 (11) : 1325.e1 - 1325.e12
  • [25] Triple therapy in patients with atrial fibrillation and acute coronary syndrome or percutaneous coronary intervention/stenting
    Koziel, Monika
    Potpara, Tatjana S.
    Lip, Gregory Y. H.
    RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2020, 4 (03) : 357 - 365
  • [26] Optimal duration of dual antiplatelet therapy post percutaneous coronary intervention in acute coronary syndrome
    Deharo, Pierre
    Cuisset, Thomas
    TRENDS IN CARDIOVASCULAR MEDICINE, 2020, 30 (04) : 198 - 202
  • [27] Antithrombotic therapy in patients with atrial fibrillation and acute coronary syndrome and / or undergoing percutaneous coronary intervention
    Mihajlovic, Miroslav
    Marinkovic, Milan
    Koziel, Monika
    Mujovic, Nebojsa
    Lip, Gregory Y. H.
    Potpara, Tatjana S.
    KARDIOLOGIA POLSKA, 2020, 78 (06) : 512 - 519
  • [28] Erythropoietin in Patients With Acute Coronary Syndrome and Its Cardioprotective Action After Percutaneous Coronary Intervention
    Nakamura, Reo
    Takahashi, Akihiko
    Yamada, Takeshi
    Miyai, Nobuyuki
    Irie, Hidekazu
    Kinoshita, Noriyuki
    Sawada, Takahisa
    Azuma, Akihiro
    Matsubara, Hiroaki
    CIRCULATION JOURNAL, 2009, 73 (10) : 1920 - 1926
  • [29] Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention or after acute coronary syndrome Practical lessons from a review
    ten Berg, J. M.
    Zwart, B.
    van't Hof, A. W. J.
    Liem, A.
    Waltenberger, J.
    de Winter, R. J.
    Jukema, J. W.
    NETHERLANDS HEART JOURNAL, 2017, 25 (12) : 655 - 663
  • [30] Multiple Life-threatening Coronary Artery Spasms after Percutaneous Coronary Intervention for Acute Coronary Syndrome
    Sawai, Toshiki
    Tajima, Yu
    Hirota, Atsuya
    Yamamoto, Shigetada
    Nakajima, Hiroshi
    Makino, Katsutoshi
    Ito, Masaaki
    INTERNAL MEDICINE, 2019, 58 (02) : 233 - 238